Literature DB >> 9149841

Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.

J Summerton1, D Stein, S B Huang, P Matthews, D Weller, M Partridge.   

Abstract

Morpholino and phosphorothioate (S-DNA) antisense oligos were compared in both cell-free and in-cell translation systems. In the most stringent test of specificity in the cell-free system, a globin-targeted S-DNA oligo was found to inhibit its target sequence at concentrations of 10 nM and above, but the sequence-specific component of this inhibition dropped below 50% at concentrations of 100 nM and above. A corresponding Morpholino oligo achieved even higher inhibition at 10 nM, but in contrast to the S-DNA, with the Morpholino, the sequence-specific component of this inhibition remained above 93% at a concentration of 3000 nM. In this same cell-free test system, several S-DNA oligos exhibited substantial undesired nonantisense effects at concentrations of 300 nM and above, whereas corresponding Morpholino oligos exhibited little or no nonantisense activity through a concentration of 3000 nM. In scrape-loaded HeLa cells, both globin-targeted and HBV-targeted S-DNAs (both antisense and control oligos) generally failed to achieve significant translational inhibition at extracellular concentrations up to 3000 nM. In contrast, the Morpholino oligos achieved effective and specific translational inhibition at extracellular concentrations ranging from 30 nM to 3000 nM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149841     DOI: 10.1089/oli.1.1997.7.63

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  45 in total

1.  Functional characterization of the dimer linkage structure RNA of Moloney murine sarcoma virus.

Authors:  H Ly; D P Nierlich; J C Olsen; A H Kaplan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.

Authors:  Angelika Gabler; Stefan Krebs; Doris Seichter; Martin Förster
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

Review 3.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  The use of Endo-Porter to deliver morpholinos in kidney organ culture.

Authors:  George N Nikopoulos; Tamara L Adams; Derek Adams; Leif Oxburgh; Igor Prudovsky; Joseph M Verdi
Journal:  Biotechniques       Date:  2008-04       Impact factor: 1.993

5.  In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Authors:  Yi Wang; Xinrong Liu; Kayoko Nakamura; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  Cancer Biother Radiopharm       Date:  2009-10       Impact factor: 3.099

6.  Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.

Authors:  Erin K Sully; Bruce L Geller; Lixin Li; Christina M Moody; Stacey M Bailey; Amy L Moore; Michael Wong; Patrice Nordmann; Seth M Daly; Carolyn R Sturge; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

Review 7.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

8.  Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.

Authors:  Paola Scaffidi; Tom Misteli
Journal:  Nat Med       Date:  2005-03-06       Impact factor: 53.440

9.  Transferrin-a modulates hepcidin expression in zebrafish embryos.

Authors:  Paula G Fraenkel; Yann Gibert; Jason L Holzheimer; Victoria J Lattanzi; Sarah F Burnett; Kimberly A Dooley; Rebecca A Wingert; Leonard I Zon
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

10.  The pro-apoptotic protein Par-4 facilitates vascular contractility by cytoskeletal targeting of ZIPK.

Authors:  Susanne Vetterkind; Kathleen G Morgan
Journal:  J Cell Mol Med       Date:  2008-05-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.